Ubs Asset Management Americas Inc Soma Logic, Inc. Transaction History

Ubs Asset Management Americas Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.76 - $2.83 $231,357 - $372,011	-131,453 Reduced 58.37%	93,748 $237,000
Q3 2023 Nov 13, 2023	BUY	$1.99 - $2.45 $50,148 - $61,740	25,200 Added 12.6%	225,201 $538,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $3.47 $208,450 - $352,840	101,683 Added 103.42%	200,001 $502,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $12,021 - $104,378	19,082 Added 24.08%	98,318 $285,000
Q2 2022 Aug 12, 2022	BUY	$4.27 - $8.26 $338,337 - $654,489	79,236 New	79,236 $358,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.